SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Christopher G. Goetz, Glenn T. Stebbins, Lu Wang, Nancy R. LaPelle, Sheng Luo, Barbara C. Tilley, IPMDS-Sponsored Scale Translation Program: Process, Format, and Clinimetric Testing Plan for the MDS-UPDRS and UDysRS, Movement Disorders Clinical Practice, 2014, 1, 2
  2. 2
    Albert Y. Hung, Michael A. Schwarzschild, Treatment of Parkinson’s Disease: What’s in the Non-dopaminergic Pipeline?, Neurotherapeutics, 2014, 11, 1, 34

    CrossRef

  3. 3
    J. Kulisevsky, M.R. Luquin, J.M. Arbelo, J.A. Burguera, F. Carrillo, A. Castro, J. Chacón, P.J. García-Ruiz, E. Lezcano, P. Mir, J.C. Martinez-Castrillo, I. Martínez-Torres, V. Puente, A. Sesar, F. Valldeoriola-Serra, R. Yañez, Advanced Parkinson's disease: Clinical characteristics and treatment (part 1), Neurología (English Edition), 2013, 28, 8, 503

    CrossRef

  4. 4
    Ludivine S. Breger, Stephen B. Dunnett, Emma L. Lane, Comparison of rating scales used to evaluate l-DOPA-induced dyskinesia in the 6-OHDA lesioned rat, Neurobiology of Disease, 2013, 50, 142

    CrossRef

  5. 5
    J. Kulisevsky, M.R. Luquin, J.M. Arbelo, J.A. Burguera, F. Carrillo, A. Castro, J. Chacón, P.J. García-Ruiz, E. Lezcano, P. Mir, J.C. Martinez-Castrillo, I. Martínez-Torres, V. Puente, A. Sesar, F. Valldeoriola-Serra, R. Yañez, Enfermedad de Parkinson avanzada. Características clínicas y tratamiento (parte I), Neurología, 2013, 28, 8, 503

    CrossRef

  6. 6
    Susan H. Fox, Tom H. Johnston, Qin Li, Jonathan Brotchie, Erwan Bezard, A critique of available scales and presentation of the non-human primate dyskinesia rating scale, Movement Disorders, 2012, 27, 11
  7. 7
    Mariana Rieck, Artur F Schumacher-Schuh, Vivian Altmann, Carolina LM Francisconi, Paulo TB Fagundes, Thaís L Monte, Sidia M Callegari-Jacques, Carlos RM Rieder, Mara H Hutz, DRD2haplotype is associated with dyskinesia induced by levodopa therapy in Parkinson’s disease patients, Pharmacogenomics, 2012, 13, 15, 1701

    CrossRef

  8. 8
    Houman Homayoun, Christopher G Goetz, Facing the unique challenges of dyskinesias in Parkinson’s disease, Future Neurology, 2012, 7, 2, 127

    CrossRef

  9. 9
    Behzad Elahi, Nicolás Phielipp, Robert Chen, N-Methyl-D-Aspartate Antagonists in Levodopa Induced Dyskinesia: A Meta-Analysis, The Canadian Journal of Neurological Sciences, 2012, 39, 04, 465

    CrossRef

  10. 10
    Todd B. Sherer, Sohini Chowdhury, Katherine Peabody, Deborah W. Brooks, Overcoming obstacles in Parkinson's disease, Movement Disorders, 2012, 27, 13
  11. 11
    P. Riederer, J. Sian-Hülsmann, The significance of neuronal lateralisation in Parkinson’s disease, Journal of Neural Transmission, 2012, 119, 8, 953

    CrossRef

  12. 12
    Nicolas Phielipp, Janis Miyasaki, Advances in Parkinson’s Disease Management, 2012,

    CrossRef

  13. 13
    Zinovia Kefalopoulou, Iciar Aviles-Olmos, Thomas Foltynie, Critical Aspects of Clinical Trial Design for Novel Cell and Gene Therapies, Parkinson's Disease, 2011, 2011, 1

    CrossRef

  14. 14
    Pablo Martinez-Martin, Martine Jeukens-Visser, Kelly E. Lyons, C. Rodriguez-Blazquez, Caroline Selai, Andrew Siderowf, Mickie Welsh, Werner Poewe, Oliver Rascol, Cristina Sampaio, Glenn T. Stebbins, Christopher G. Goetz, Anette Schrag, Health-related quality-of-life scales in Parkinson's disease: Critique and recommendations, Movement Disorders, 2011, 26, 13
  15. 15
    Wassilios G. Meissner, Mark Frasier, Thomas Gasser, Christopher G. Goetz, Andres Lozano, Paola Piccini, José A. Obeso, Olivier Rascol, Anthony Schapira, Valerie Voon, David M. Weiner, François Tison, Erwan Bezard, Priorities in Parkinson's disease research, Nature Reviews Drug Discovery, 2011, 10, 5, 377

    CrossRef

  16. 16
    Christopher G. Goetz, Glenn T. Stebbins, Ad Theeuwes, Fabrizio Stocchi, Joaquim J. Ferreira, Serge van de Witte, Juliana Bronzova, Temporal stability of the Unified Dyskinesia Rating Scale, Movement Disorders, 2011, 26, 14
  17. 17
    Kenneth Marek, Danna Jennings, Shirley Lasch, Andrew Siderowf, Caroline Tanner, Tanya Simuni, Chris Coffey, Karl Kieburtz, Emily Flagg, Sohini Chowdhury, Werner Poewe, Brit Mollenhauer, Paracelsus-Elena Klinik, Todd Sherer, Mark Frasier, Claire Meunier, Alice Rudolph, Cindy Casaceli, John Seibyl, Susan Mendick, Norbert Schuff, Ying Zhang, Arthur Toga, Karen Crawford, Alison Ansbach, Pasquale De Blasio, Michele Piovella, John Trojanowski, Les Shaw, Andrew Singleton, Keith Hawkins, Jamie Eberling, Deborah Brooks, David Russell, Laura Leary, Stewart Factor, Barbara Sommerfeld, Penelope Hogarth, Emily Pighetti, Karen Williams, David Standaert, Stephanie Guthrie, Robert Hauser, Holly Delgado, Joseph Jankovic, Christine Hunter, Matthew Stern, Baochan Tran, Jim Leverenz, Marne Baca, Sam Frank, Cathi-Ann Thomas, Irene Richard, Cheryl Deeley, Linda Rees, Fabienne Sprenger, Elisabeth Lang, Holly Shill, Sanja Obradov, Hubert Fernandez, Adrienna Winters, Daniela Berg, Katharina Gauss, Douglas Galasko, Deborah Fontaine, Zoltan Mari, Melissa Gerstenhaber, David Brooks, Sophie Malloy, Paolo Barone, Katia Longo, Tom Comery, Bernard Ravina, Igor Grachev, Kim Gallagher, Michelle Collins, Katherine L. Widnell, Suzanne Ostrowizki, Paulo Fontoura, Tony Ho, Johan Luthman, Marcel van der Brug, Alastair D. Reith, Peggy Taylor, The Parkinson Progression Marker Initiative (PPMI), Progress in Neurobiology, 2011, 95, 4, 629

    CrossRef

  18. 18
    Mildred D. Gottwald, Michael J. Aminoff, Therapies for dopaminergic-induced dyskinesias in parkinson disease, Annals of Neurology, 2011, 69, 6
  19. 19
    Angelo Antonini, Pablo Martinez-Martin, Ray K. Chaudhuri, Marcelo Merello, Robert Hauser, Regina Katzenschlager, Per Odin, Mark Stacy, Fabrizio Stocchi, Werner Poewe, Oliver Rascol, Cristina Sampaio, Anette Schrag, Glenn T. Stebbins, Christopher G. Goetz, Wearing-off scales in Parkinson's disease: Critique and recommendations, Movement Disorders, 2011, 26, 12
  20. 20
    L.K. Prashanth, Susan Fox, Wassilios G. Meissner, Pathophysiology, Pharmacology, and Biochemistry of Dyskinesia, 2011,

    CrossRef

  21. 21
    Tom H. Johnston, Emma L. Lane, Pathophysiology, Pharmacology, and Biochemistry of Dyskinesia, 2011,

    CrossRef

  22. 22
    Ainhi D. Ha, Joseph Jankovic, Pathophysiology, Pharmacology, and Biochemistry of Dyskinesia, 2011,

    CrossRef

  23. 23
    P. Krystkowiak, La maladie de Parkinson, 2011,

    CrossRef

  24. 24
    E. Hametner, K. Seppi, W. Poewe, The clinical spectrum of levodopa-induced motor complications, Journal of Neurology, 2010, 257, S2, 268

    CrossRef

  25. 25
    S. Elizabeth Zauber, Christopher G. Goetz, Dyskinesias in Parkinsonian Syndromes,